Hikal Limited has disclosed a procedural change within its promoter group. Castilia Life Sciences Private Limited has officially converted into a Limited Liability Partnership (LLP), now known as Castilia Life Sciences LLP. This conversion, effective after the Ministry of Corporate Affairs issued the registration certificate on February 17, 2026, results in the vesting of all previous assets, rights, and liabilities, including shareholding in Hikal, to the new LLP structure. The Company confirmed compliance with all relevant disclosure requirements.
Promoter Group Entity Restructures
Hikal Limited has formally announced a significant structural change involving an entity within its promoter group. Castilia Life Sciences Private Limited, a key promoter shareholder, has undergone a conversion process to become a Limited Liability Partnership (LLP).
The conversion was successfully completed following the approval and issuance of the Certificate of Registration by the Ministry of Corporate Affairs on February 17, 2026. The newly formed entity will operate as Castilia Life Sciences LLP.
Impact of Conversion
This procedural change dictates that all existing assets, rights, liabilities, and interests previously held by Castilia Life Sciences Private Limited have been legally vested in the newly formed Castilia LLP. This includes the entirety of the promoter entity’s shareholding in Hikal Limited.
Hikal Limited confirmed receipt of the formal intimation regarding this change from Castilia Life Sciences LLP and has made the necessary disclosure to stock exchanges, emphasizing adherence to all applicable regulatory provisions.
Source: BSE
